Ligand ID: OAQ


Drugbank ID:
DB01096
(Oxamniquine)


Indication:
For treatment of Schistosomiasis caused by Schistosoma mansoni

Get human targets for OAQ in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'OAQ'

Click here for results that match SARS-Cov-2 / COVID-19 structures only
Click here for results that match SARS-related structures only


1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		1q2w 3C-LIKE PROTEASE
(SARSr-CoV)		6 / 12
ILE B 249
ILE B 200
LEU B 250
LEU B 242
THR B 201
LEU B 205
1.44A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIY_A_OAQA302_0
(SULFOTRANSFERASE)		1uk3 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
PRO B  39
ILE B 136
PHE B 140
SER B 147
LEU B 167
1.76A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		1uk3 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO B  39
LEU B  27
PHE B 140
SER B 144
THR B 135
1.63A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		1wnc E2 GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ILE B 916
VAL B1170
LEU C 920
THR B 923
LEU C1167
1.61A19.42
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		1x7q BETA-2-MICROGLOBULIN
HLA, A-11
(Homo
sapiens)		5 / 12
LEU B  54
VAL A  12
ASP A 119
SER B  33
LEU A  81
1.39A17.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		1zv8 E2 GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ILE I  16
VAL H  22
LEU K  20
THR I  23
LEU J  19
1.54A12.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		2a5i 3C-LIKE PEPTIDASE
(SARSr-CoV)		5 / 12
ILE A 249
LEU A 250
PHE A 294
LEU A 242
THR A 201
1.32A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		2a5i 3C-LIKE PEPTIDASE
(SARSr-CoV)		5 / 12
ILE A 249
LEU A 250
PHE A 294
THR A 201
LEU A 205
1.55A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		2a5i 3C-LIKE PEPTIDASE
(SARSr-CoV)		5 / 12
ILE A 249
ILE A 200
PHE A 294
LEU A 242
THR A 201
1.39A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		2a5k 3C-LIKE PEPTIDASE
(SARSr-CoV)		7 / 12
ILE A 249
ILE A 200
LEU A 250
PHE A 294
LEU A 242
THR A 201
LEU A 205
1.58A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		2ahm REPLICASE
POLYPROTEIN 1AB,
HEAVY CHAIN
(SARSr-CoV)		5 / 12
ILE F 161
LEU F 133
VAL F 137
VAL F 135
LEU F 174
1.55A22.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		2ahm REPLICASE
POLYPROTEIN 1AB,
HEAVY CHAIN
REPLICASE
POLYPROTEIN 1AB,
LIGHT CHAIN
(SARSr-CoV)		5 / 12
MET G  72
LEU H 122
VAL H 120
LEU D  60
LEU D  18
1.56A20.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		2ajf ACE2
(Homo
sapiens)		5 / 12
PRO B 415
HIS B 417
VAL B 293
ASP B 367
MET B 297
1.41A17.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		2beq SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ILE B 916
VAL D1171
LEU C 920
THR B 923
LEU E1168
1.59A10.33
ACE  B 913 ( 3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		5 / 12
LEU A  13
VAL A  93
VAL A  94
LEU A  55
LEU B  22
1.37A17.70
None
None
None
D10  B1099 ( 4.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		5 / 12
LEU H  13
VAL H  93
VAL H  94
LEU H  55
LEU G  22
1.34A16.54
None
None
None
D10  H1099 ( 4.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		5 / 12
LEU E  13
VAL E  93
VAL E  94
LEU E  55
LEU F  22
1.36A17.70
None
None
None
D10  F1099 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		5 / 12
PRO H  40
ILE G  20
VAL H  42
LEU G  55
THR G  23
1.56A19.69
None
None
None
D10  H1099 ( 4.8A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		2d2d 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO B  39
HIS B 163
LEU B  27
THR B  25
THR B 190
1.62A21.23
None
ENB  B1145 (-3.7A)
ENB  B1145 (-4.2A)
ENB  B1145 ( 4.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		2d2d 3C-LIKE PROTEINASE
(SARSr-CoV)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.40A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		2dd8 IGG LIGHT CHAIN
(Homo
sapiens)		5 / 12
PRO L  15
ILE L  75
VAL L  13
LEU L  73
THR L 102
1.49A19.38
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		2dd8 IGG HEAVY CHAIN
(Homo
sapiens)		6 / 12
PRO H 126
LEU H 189
VAL H 182
VAL H 184
SER H 188
THR H 160
1.73A22.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		2fe8 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
PHE A 305
LEU A 102
GLY A 164
MET A 170
THR A 169
1.50A21.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_1
(SULFOTRANSFERASE)		2ghw ANTI-SCFV ANTIBODY,
80R
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARSr-CoV)		4 / 4
TYR A 440
ASP B 182
ASP A 392
SER B 101
1.77A20.85
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		2h85 PUTATIVE ORF1AB
POLYPROTEIN
(SARSr-CoV)		5 / 12
ILE A 306
LEU A 299
VAL A 236
LEU A 331
THR A 340
1.62A21.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		2h85 PUTATIVE ORF1AB
POLYPROTEIN
(SARSr-CoV)		5 / 12
PRO A  93
ILE A  79
LEU A  57
LEU A 119
THR A 105
1.57A21.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		2k7x REPLICASE
POLYPROTEIN 1AB MAIN
PROTEASE
(SARS-COV
Sino1-11)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.40A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		2op9 REPLICASE
POLYPROTEIN 1AB
(PP1AB, ORF1AB)
3C-LIKE PROTEINASE
(3CL-PRO, 3CLP)
(SARSr-CoV)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.48A20.66
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 12
PRO D  93
ILE D  79
LEU D  57
LEU D 119
THR D 105
1.48A21.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 12
ILE B 235
LEU B 248
VAL B 318
PHE B 302
LEU B 311
1.27A22.16
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 12
ILE B 235
ASP B 239
LEU B 248
PHE B 302
LEU B 311
1.27A21.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		2pwx 3C-LIKE PROTEINASE
(SARS-COV
BJ01)		5 / 12
ILE A 249
LEU A 250
PHE A 294
THR A 201
LEU A 205
1.55A20.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		2pwx 3C-LIKE PROTEINASE
(SARS-COV
BJ01)		5 / 12
ILE A 249
LEU A 250
PHE A 294
LEU A 242
THR A 201
1.31A19.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		2pwx 3C-LIKE PROTEINASE
(SARS-COV
BJ01)		7 / 12
ILE A 249
ILE A 200
LEU A 250
PHE A 294
LEU A 242
THR A 201
LEU A 205
1.46A20.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		2pwx 3C-LIKE PROTEINASE
(SARS-COV
BJ01)		5 / 12
ILE A 249
ILE A 200
PHE A 294
LEU A 242
THR A 201
1.35A20.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		2q6g REPLICASE
POLYPROTEIN 1AB
(SARS-COV
BJ01)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.39A21.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		2qc2 3C-LIKE PROTEINASE
(-)		5 / 12
PRO A 168
MET A 165
LEU A 167
PHE A 181
MET A  49
1.67A21.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		2qc2 3C-LIKE PROTEINASE
(-)		5 / 12
PRO A 168
MET A 165
LEU A 167
PHE A 181
MET A  49
1.64A21.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		2qc2 3C-LIKE PROTEINASE
(-)		5 / 12
ILE A 136
LEU A 115
VAL A 148
PHE A 140
THR A 175
1.62A19.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		2qc2 3C-LIKE PROTEINASE
(-)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.44A19.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		2qcy 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ILE A 249
LEU A 250
PHE A 294
LEU A 242
THR A 201
1.40A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		2qcy 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ILE A 249
LEU A 250
PHE A 294
THR A 201
LEU A 205
1.62A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		2qcy 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO A 168
MET A 165
LEU A 167
PHE A 181
MET A  49
1.75A21.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		2qcy 3C-LIKE PROTEINASE
(SARSr-CoV)		7 / 12
ILE A 249
ILE A 200
LEU A 250
PHE A 294
LEU A 242
THR A 201
LEU A 205
1.50A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		2qiq REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.48A20.66
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 12
ILE B 306
LEU B 299
VAL B 236
LEU B 331
THR B 340
1.48A21.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 12
ILE B 306
LEU B 299
VAL B 236
LEU B 331
THR B 340
1.46A21.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 12
LEU C 167
VAL C 172
GLY C 125
PHE C 176
THR C 174
1.57A21.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		2vj1 MAIN PROTEINASE
(SARSr-CoV)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.42A20.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		2w2g NSP3
(SARSr-CoV)		5 / 12
PRO A 479
ILE A 454
VAL A 457
VAL A 448
LEU A 421
1.38A23.39
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		2wct NSP3
(SARSr-CoV)		5 / 12
PRO A 479
PHE A 414
VAL A 448
GLY A 419
THR A 450
1.62A23.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		2xyq PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		5 / 12
ILE A 128
VAL A  84
LEU A 126
THR A  82
LEU A  59
1.36A20.89
None
None
None
None
NA  A1295 (-4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		2xyq PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		6 / 12
ILE A 127
LEU A 111
VAL A 288
VAL A 290
LEU A 161
PHE A 156
1.65A22.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		2xyq NSP10
PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		5 / 10
LEU B  45
VAL A  84
PHE A 250
THR A  48
THR A  93
1.77A15.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		2xyq PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		6 / 12
ILE A 127
LEU A 111
VAL A 288
VAL A 290
LEU A 161
PHE A 156
1.77A20.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		2xyr PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		5 / 12
ILE A 128
VAL A  84
LEU A 126
THR A  82
LEU A  59
1.35A21.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		2xyv PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		6 / 12
ILE A 127
LEU A 111
VAL A 288
VAL A 290
LEU A 161
PHE A 156
1.76A21.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		2xyv PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		6 / 12
ILE A 127
LEU A 111
VAL A 288
VAL A 290
LEU A 161
PHE A 156
1.64A22.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		2xyv NSP10
PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		5 / 10
LEU B  45
VAL A  84
PHE A 250
THR A  48
THR A  93
1.79A18.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		3aw0 3C-LIKE PROTEINASE
(SARSr-CoV)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.46A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		3bgf F26G19 FAB
(Mus
musculus)		5 / 12
PRO C 113
MET C 175
VAL C 115
ILE C 117
LEU B 124
1.41A22.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIY_A_OAQA302_0
(SULFOTRANSFERASE)		3bgf F26G19 FAB
(Mus
musculus)		5 / 11
ASP H  86
VAL H  18
MET H  80
LEU H  69
THR H  70
1.52A23.66
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		3d0g ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
ASP A 367
LEU A 370
ILE A 446
SER A 409
THR A 449
1.30A18.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		3d0h ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
ILE B 407
VAL B 573
VAL B 574
MET B 557
LEU B 558
0.97A18.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		3d0h ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
VAL B 485
VAL B 487
LEU B 503
MET B 455
THR B 453
1.60A16.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		3d0h ACE2
SPIKE GLYCOPROTEIN
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
LEU A 359
GLY E 488
ASP A 355
MET A 323
THR A 324
1.50A16.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		3d0h ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
LEU A 444
ASP A 367
LEU A 370
THR A 276
THR A 294
1.08A18.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		3d0i ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
PRO A 415
HIS A 417
VAL A 293
ASP A 367
MET A 297
1.44A17.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		3d62 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO A 168
MET A 165
LEU A 167
PHE A 181
MET A  49
1.76A21.70
None
959  A 350 (-4.4A)
None
None
959  A 350 (-4.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		3e9s NSP3
(SARSr-CoV)		5 / 10
MET A 209
LEU A 212
ASP A 165
MET A 170
THR A 169
1.79A21.87
None
None
TTT  A 317 (-4.1A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		3e9s NSP3
(SARSr-CoV)		5 / 12
PHE A 305
LEU A 102
GLY A 164
MET A 170
THR A 169
1.46A21.30
None
None
TTT  A 317 (-3.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		3ea7 3C-LIKE PROTEINASE
(SARSr-CoV)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.43A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		3ea9 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO A 168
MET A 165
LEU A 167
PHE A 181
MET A  49
1.78A21.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		3ea9 3C-LIKE PROTEINASE
(SARSr-CoV)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.48A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		3eaj 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
MET A 235
LEU A 232
LEU B 227
THR B 225
LEU B 262
1.34A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		3ebn REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		7 / 12
ILE A 249
ILE C 200
LEU A 250
PHE A 294
LEU A 242
THR C 201
LEU C 205
1.62A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		3f9g 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
LEU A  67
VAL A  91
VAL A  77
PHE A  66
SER A  65
1.79A21.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		3f9g 3C-LIKE PROTEINASE
(SARSr-CoV)		6 / 12
ILE B 249
ILE B 200
LEU B 250
LEU B 242
THR B 201
LEU B 205
1.44A20.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		3f9h 3C-LIKE PROTEINASE
(SARSr-CoV)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.45A20.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		3fzd 3C-LIKE PROTEINASE
(SARSr-CoV)		7 / 12
ILE A 249
ILE A 200
LEU A 250
PHE A 294
LEU A 242
THR A 201
LEU A 205
1.53A21.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		3fzd 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ILE A 249
LEU A 250
PHE A 294
THR A 201
LEU A 205
1.63A21.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		3i6g BETA-2-MICROGLOBULIN
HLA, A-2
(Homo
sapiens)		5 / 12
LEU E  54
VAL D  12
ASP D 119
SER E  33
LEU D  81
1.38A16.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		3iwm 3C-LIKE PROTEINASE
(SARSr-CoV)		6 / 12
ILE C 249
ILE A 200
LEU C 250
LEU C 242
THR A 201
LEU A 205
1.39A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		3iwm 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO B  52
LEU B  50
GLY B 174
THR B 190
THR B 175
1.64A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		3m3s 3C-LIKE PROTEINASE
(SARSr-CoV)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.44A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		3m3t 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO A 168
MET A 165
LEU A 167
PHE A 181
MET A  49
1.67A21.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		3m3t 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO A 168
MET A 165
LEU A 167
PHE A 181
MET A  49
1.65A21.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		3m3v 3C-LIKE PROTEINASE
(SARSr-CoV)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.48A20.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		3mj5 REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		5 / 10
MET B 209
LEU B 212
ASP B 165
MET B 170
THR B 169
1.79A21.99
GRM  A 801 (-4.2A)
None
GRM  B 801 (-3.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		3mj5 REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		5 / 12
ASP A 287
THR A 266
MET A 294
THR A 292
LEU A 291
1.53A19.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		3r24 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		5 / 12
ILE A 128
VAL A  84
LEU A 126
THR A  82
LEU A  59
1.35A19.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		3r24 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		6 / 12
ILE A 127
LEU A 111
VAL A 288
VAL A 290
LEU A 161
PHE A 156
1.62A21.95
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		3r24 2'-O-METHYL
TRANSFERASE
NSP10 AND NSP11
(SARSr-CoV)		5 / 10
LEU B  45
VAL A  84
PHE A 250
THR A  48
THR A  93
1.74A19.07
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		3r24 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		6 / 12
ILE A 127
LEU A 111
VAL A 288
VAL A 290
LEU A 161
PHE A 156
1.73A19.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		3sci ACE2
(Homo
sapiens)		5 / 12
ILE B 407
VAL B 573
VAL B 574
MET B 557
LEU B 558
1.07A17.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		3sci ACE2
(Homo
sapiens)		5 / 12
ASP A 367
LEU A 370
ILE A 446
SER A 409
THR A 449
1.49A17.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		3scj ACE2
(Homo
sapiens)		5 / 12
PRO B 415
HIS B 417
VAL B 293
ASP B 367
MET B 297
1.40A17.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		3sck ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
LEU A 444
ASP A 367
LEU A 370
THR A 276
THR A 294
1.46A17.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		3sck ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
PRO B 415
HIS B 417
VAL B 293
ASP B 367
MET B 297
1.47A17.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		3sck ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
ILE B 407
VAL B 573
VAL B 574
MET B 557
LEU B 558
1.10A17.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		3sck ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 10
ILE B 358
ASP B 382
PHE B 327
THR B 324
THR B  52
1.68A17.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		3scl ACE2
SPIKE GLYCOPROTEIN
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
LEU A 359
GLY E 488
ASP A 355
MET A 323
THR A 324
1.55A17.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		3scl ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
PRO B 590
ILE B 233
ILE B 446
LEU B 520
THR B 519
1.54A17.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		4hi3 3C-LIKE PROTEINASE
(SARSr-CoV)		7 / 12
ILE A 249
ILE A 200
LEU A 250
PHE A 294
LEU A 242
THR A 201
LEU A 205
1.51A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		4hi3 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ILE A 249
LEU A 250
PHE A 294
LEU A 242
THR A 201
1.37A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		4hi3 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO A 168
MET A 165
LEU A 167
PHE A 181
MET A  49
1.73A21.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		4hi3 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ILE A 249
ILE A 200
PHE A 294
LEU A 242
THR A 201
1.44A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		4hi3 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ILE A 249
LEU A 250
PHE A 294
THR A 201
LEU A 205
1.60A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		4m0w REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		5 / 12
PHE A 305
LEU A 102
GLY A 164
MET A 170
THR A 169
1.53A21.22
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		4ovz PAPAIN-LIKE
PROTEINASE
(SARS-COV
Urbani)		5 / 12
PHE A 305
LEU A 102
GLY A 164
MET A 170
THR A 169
1.46A21.43
None
None
DMS  A 903 (-3.0A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		4wy3 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO A  39
LEU A  27
PHE A 140
SER A 144
THR A 135
1.70A21.63
None
None
None
3X5  A 401 ( 3.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		5c5o 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ILE B 249
LEU B 250
PHE B 294
THR B 201
LEU B 205
1.61A20.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		5c8s GUANINE-N7
METHYLTRANSFERASE
NSP10
(SARSr-CoV)		5 / 12
LEU C  75
VAL C  13
GLY D  59
PHE D   8
MET D  62
1.60A19.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		5c8s GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
PRO D 412
HIS D 427
LEU D 411
ASP D 402
PHE D 401
1.70A19.96
None
None
None
None
G3A  D 606 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		5c8s GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
ILE B 164
LEU B 170
VAL B 236
SER B 171
THR B 219
1.35A19.42
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		5c8s GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
ILE B  55
LEU B 105
ASP B  10
THR B 103
LEU B  18
1.42A18.64
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		5c8t GUANINE-N7
METHYLTRANSFERASE
(SARSr)		5 / 12
ILE B 164
LEU B 170
VAL B 236
SER B 171
THR B 219
1.36A18.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		5c8t GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
PRO D 412
HIS D 427
LEU D 411
ASP D 402
PHE D 401
1.73A19.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		5c8u GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
ILE B  55
LEU B 105
ASP B  10
THR B 103
LEU B  18
1.50A17.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		5c8u GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
ILE D 164
LEU D 170
VAL D 236
SER D 171
THR D 219
1.53A17.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		5e6j UBIQUITIN
(synthetic
construct)		5 / 12
ILE B  36
ASP B  32
LEU B  71
THR B   9
LEU B   8
1.41A17.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		5e6j REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
PHE D 305
LEU D 102
GLY D 164
MET D 170
THR D 169
1.54A20.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 12
LEU N  75
VAL N  13
GLY B  59
PHE B   8
MET B  62
1.56A18.97
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 12
ILE A  55
LEU A 105
ASP A  10
THR A 103
LEU A  18
1.44A18.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 12
PRO A 412
HIS A 427
LEU A 411
ASP A 402
PHE A 401
1.60A19.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 12
PRO A 412
HIS A 427
LEU A 411
ASP A 402
PHE A 401
1.60A19.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		5r81 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
PRO A 168
MET A 165
LEU A 167
PHE A 181
MET A  49
1.71A22.26
RZJ  A1001 (-3.6A)
RZJ  A1001 (-3.7A)
None
None
RZJ  A1001 (-3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.69A18.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.44A18.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
ILE A 249
LEU A 250
PHE A 294
LEU A 242
LEU A 205
1.38A18.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
LEU A  67
VAL A  91
VAL A  77
LEU A  30
LEU A  32
1.44A18.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		5tl6 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
PHE D 305
LEU D 102
GLY D 164
MET D 170
THR D 169
1.56A21.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		5tl6 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
ILE B 277
THR B 266
MET B 294
THR B 292
LEU B 291
1.61A19.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		5tl6 UBIQUITIN-LIKE
PROTEIN ISG15
(Homo
sapiens)		5 / 12
ILE A  84
LEU A 124
VAL A 104
LEU A  82
THR A 101
1.52A13.20
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		5tl7 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 10
MET D 209
LEU D 212
ASP D 165
MET D 170
THR D 169
1.72A21.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ASP C 600
VAL A 842
ASP A 757
LEU A 846
LEU A 847
1.62A11.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		5x29 ENVELOPE SMALL
MEMBRANE PROTEIN
(SARSr-CoV)		5 / 10
ILE C  46
LEU C  27
VAL D  29
THR C  30
THR D  35
1.64A14.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		5x4r S PROTEIN
(MERS-CoV)		5 / 12
ILE A 256
LEU A  74
LEU A 169
PHE A 112
LEU A 284
1.40A23.12
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		5x4s SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO A 136
ILE A  81
VAL A 102
ILE A 228
THR A 229
1.52A19.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		5x58 SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 12
ILE C 852
VAL C 767
LEU C 847
MET C 770
LEU B 681
1.39A11.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 12
ILE C 219
VAL C 123
ILE C 116
PHE C 220
SER C 165
1.45A11.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIY_A_OAQA302_0
(SULFOTRANSFERASE)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 11
PRO B1035
MET B1032
VAL B 860
PHE B 880
LEU B 876
1.66A11.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 12
PHE B 782
VAL B1047
GLY B 867
PHE B1034
MET B 884
1.45A12.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 12
PRO C 210
HIS C  33
VAL C 206
VAL C 205
THR C  92
1.48A12.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		5x5c S PROTEIN
(MERS-CoV)		5 / 12
ILE A 662
LEU A 347
VAL A 363
LEU A 735
LEU A 715
1.64A10.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		5x5c S PROTEIN
(MERS-CoV)		5 / 12
ILE A 782
ILE A 985
PHE B 967
LEU A 990
THR A 986
1.47A10.95
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		5x5c S PROTEIN
(MERS-CoV)		5 / 12
LEU C 344
VAL C 360
VAL C 661
ASP A 805
THR A 803
1.79A11.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_1
(SULFOTRANSFERASE)		5x5c S PROTEIN
(MERS-CoV)		4 / 4
TYR B 642
ASP B 645
ASP B 580
SER B 583
1.34A10.95
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		5x5f S PROTEIN
(MERS-CoV)		5 / 12
HIS A 670
ILE A 662
VAL A 659
VAL A 363
LEU A 735
1.07A11.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		5x5f S PROTEIN
(MERS-CoV)		5 / 12
ILE C 256
LEU C  74
LEU C 169
PHE C 112
LEU C 284
1.38A10.95
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO A 697
LEU C 876
GLY A1026
ASP A1023
THR C 869
1.62A12.16
PRO  A 697 ( 1.1A)
LEU  C 876 ( 0.6A)
GLY  A1026 ( 0.0A)
ASP  A1023 ( 0.5A)
THR  C 869 ( 0.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO A 617
LEU A 615
VAL A 581
ASP A 600
THR C 841
1.69A12.24
PRO  A 617 ( 1.1A)
LEU  A 615 ( 0.6A)
VAL  A 581 ( 0.6A)
ASP  A 600 ( 0.5A)
THR  C 841 ( 0.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 10
ILE C 787
LEU C 859
VAL C1015
THR C 863
THR C 705
1.52A12.24
ILE  C 787 ( 0.7A)
LEU  C 859 ( 0.6A)
VAL  C1015 ( 0.6A)
THR  C 863 ( 0.8A)
THR  C 705 ( 0.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		5y3e REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		5 / 10
MET A 209
LEU A 212
ASP A 165
MET A 170
THR A 169
1.78A21.49
None
None
GOL  A 408 (-3.2A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		5y3e REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		5 / 12
PHE A 305
LEU A 102
GLY A 164
MET A 170
THR A 169
1.56A20.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ASP B 790
LEU B 804
THR B 795
THR B 921
LEU B 920
1.50A11.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6acg ACE2
(Homo
sapiens)		5 / 10
ILE D 358
ASP D 382
PHE D 327
THR D 324
THR D  52
1.71A17.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO B 210
HIS B  33
VAL B 206
VAL B 205
THR B  92
1.34A12.16
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIY_A_OAQA302_0
(SULFOTRANSFERASE)		6acj SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 11
ILE B 570
ASP B 518
VAL B 525
ASP B 572
LEU B 532
1.70A12.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6acj SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ILE B 674
LEU B 283
VAL B 583
ILE B 299
LEU B 636
1.46A12.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6ack ACE2
(Homo
sapiens)		5 / 12
LEU D 444
ASP D 367
LEU D 370
THR D 276
THR D 294
1.41A16.97
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO C 697
LEU B 876
GLY C1026
ASP C1023
THR B 869
1.30A12.16
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO B 210
HIS B  33
LEU B 209
VAL B 206
VAL B 205
1.71A12.24
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 10
ILE A 787
LEU A 859
VAL A1015
THR A 863
THR A 705
1.53A12.24
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PRO A 136
ILE A  81
VAL A 102
ILE A 228
THR A 229
1.45A11.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PHE C 782
VAL C1047
GLY C 867
PHE C1034
MET C 884
1.42A12.12
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PHE A 782
VAL A1047
GLY A 867
PHE A1034
MET A 884
1.35A12.07
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6crz SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PRO A1072
ILE A 696
ILE B 878
PHE A1057
THR B 869
1.22A11.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6cs1 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 10
ILE B 787
LEU B 859
VAL B1015
THR B 863
THR B 705
1.38A12.07
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6cs1 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
ILE B 787
LEU B 859
VAL B1015
THR B 863
THR B 705
1.37A11.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6cs1 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PRO C 210
HIS C  33
VAL C 206
VAL C 205
THR C  92
1.37A12.07
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6cs2 ACE2
(Homo
sapiens)		6 / 12
VAL D 485
VAL D 487
LEU D 503
MET D 455
LEU D 456
THR D 453
1.70A17.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6cs2 ACE2
SPIKE
GLYCOPROTEIN,FIBRITI
N
(Homo
sapiens;
SARSr-CoV)		5 / 12
LEU D 359
GLY B 488
ASP D 355
MET D 323
THR D 324
1.53A16.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6cs2 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PRO A 210
HIS A  33
LEU A 209
VAL A 206
VAL A 205
1.64A12.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6jyt HELICASE
(SARSr-CoV)		5 / 12
PRO A 364
LEU A 352
VAL A 371
VAL A 305
LEU A 252
1.42A17.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6jyt HELICASE
(SARSr-CoV)		5 / 12
PRO A 364
LEU A 352
VAL A 371
VAL A 305
ASP A 369
1.63A17.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6jyt HELICASE
(SARSr-CoV)		5 / 12
ILE B 109
ASP B 119
LEU B 122
THR B 141
THR A 115
1.35A16.97
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6jyt HELICASE
(SARSr-CoV)		5 / 12
PRO A 364
LEU A 352
VAL A 305
GLY A 251
ASP A 369
1.63A17.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6lxt SPIKE PROTEIN S2
(SARS-CoV-2)		6 / 12
LEU E1166
ILE D1169
LEU D 962
PHE F 970
LEU E 959
LEU D 959
1.47A19.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6lxt SPIKE PROTEIN S2
(SARS-CoV-2)		5 / 12
ILE C 934
VAL C1189
LEU B 938
THR C 941
LEU B1186
1.55A17.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6lze VIRAL PROTEASE
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.46A21.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6lze VIRAL PROTEASE
(SARS-CoV-2)		5 / 12
LEU A  67
VAL A  91
VAL A  77
LEU A  30
LEU A  32
1.49A21.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6lze VIRAL PROTEASE
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.69A21.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6lzg ACE2
(Homo
sapiens)		5 / 12
ASP A 367
LEU A 370
ILE A 446
SER A 409
THR A 449
1.46A17.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6m03 MAIN PROTEASE
(SARS-CoV-2)		5 / 12
ILE A 249
LEU A 250
PHE A 294
LEU A 242
THR A 201
1.34A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6m03 MAIN PROTEASE
(SARS-CoV-2)		5 / 12
ILE A 249
LEU A 250
PHE A 294
THR A 201
LEU A 205
1.57A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m03 MAIN PROTEASE
(SARS-CoV-2)		7 / 12
ILE A 249
ILE A 200
LEU A 250
PHE A 294
LEU A 242
THR A 201
LEU A 205
1.43A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6m0k VIRAL PROTEASE
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.69A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m0k VIRAL PROTEASE
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.46A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6m17 ACE2
RECEPTOR BINDING
DOMAIN
(Homo
sapiens;
SARS-CoV-2)		5 / 12
LEU B 359
GLY E 502
ASP B 355
MET B 323
THR B 324
1.48A15.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6m17 ACE2
(Homo
sapiens)		5 / 12
ILE B 407
VAL B 573
VAL B 574
MET B 557
LEU B 558
1.31A14.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6m17 ACE2
(Homo
sapiens)		5 / 12
ASP B 367
LEU B 370
ILE B 446
SER B 409
THR B 449
1.39A16.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6m17 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 12
ILE A 132
LEU A 427
VAL A  55
ASP A 486
LEU A 482
1.36A16.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6m18 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 12
PRO C  59
LEU C 398
VAL C 320
VAL C 321
PHE C 420
1.68A16.44
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIY_A_OAQA302_0
(SULFOTRANSFERASE)		6m18 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 11
PRO C 442
VAL C 441
PHE C 289
SER C 288
LEU C 208
1.76A16.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIY_A_OAQA302_0
(SULFOTRANSFERASE)		6m1d ACE2
(Homo
sapiens)		5 / 11
ILE B 544
ASP B 543
SER B 317
LEU B 410
THR B 414
1.52A16.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6m1d SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 12
PRO C 265
ILE C 545
VAL C 552
VAL C 551
LEU C 495
1.19A16.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		6 / 12
ILE C 249
ILE C 200
LEU C 250
LEU C 242
THR C 201
LEU C 205
1.49A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.55A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
ILE C 281
VAL C 212
LEU C 287
MET C 264
LEU C 268
1.63A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
ILE A 136
LEU A 115
VAL A 148
PHE A 140
THR A 175
1.69A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
ILE B 281
VAL B 212
LEU B 287
MET B 264
LEU B 268
1.69A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.68A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		6 / 12
ILE B 249
ILE B 200
LEU B 250
LEU B 242
THR B 201
LEU B 205
1.53A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		6 / 12
ILE D 249
ILE D 200
LEU D 250
LEU D 242
THR D 201
LEU D 205
1.46A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
LEU B  67
VAL B  91
VAL B  77
LEU B  30
LEU B  32
1.50A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
ILE D 281
VAL D 212
LEU D 287
MET D 264
LEU D 268
1.67A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
ILE C 249
LEU C 250
PHE C 294
LEU C 242
LEU C 205
1.31A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m2q 3CL PROTEASE
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.46A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m2q 3CL PROTEASE
(SARS-CoV-2)		5 / 12
ILE A 249
LEU A 250
PHE A 294
LEU A 242
LEU A 205
1.49A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6m2q 3CL PROTEASE
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.66A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m2q 3CL PROTEASE
(SARS-CoV-2)		5 / 12
LEU A  67
VAL A  91
VAL A  77
LEU A  30
LEU A  32
1.47A21.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP7
NSP8
(SARS-CoV-2)		5 / 12
VAL C  66
ILE C  68
LEU C  56
LEU D  91
LEU D  95
1.14A17.39
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
NSP8
(SARS-CoV-2)		5 / 12
PRO A 378
ILE B 119
VAL A 341
VAL A 330
LEU A 271
1.64A14.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
(SARS-CoV-2)		5 / 12
MET A 755
ILE A 696
LEU A 749
VAL A 475
LEU A 638
1.72A15.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
(SARS-CoV-2)		5 / 12
ASP A 164
LEU A 146
PHE A 134
THR A 248
LEU A 178
1.63A15.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIY_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
NSP8
(SARS-CoV-2)		5 / 11
PHE A 368
SER A 518
MET B  90
LEU B  91
THR B  89
1.74A15.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP7
NSP8
(SARS-CoV-2)		5 / 12
ILE D 107
LEU C  56
LEU D  91
THR C   9
LEU C  13
1.01A20.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
(SARS-CoV-2)		5 / 12
ILE A 244
ASP A 465
LEU A 127
THR A 123
LEU A 212
1.53A15.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
(SARS-CoV-2)		5 / 12
ILE A 632
VAL A 693
LEU A 663
MET A 626
THR A 680
1.72A14.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6m71 NSP12
(SARS-CoV-2)		5 / 12
PRO A 809
LEU A 602
VAL A 763
ILE A 757
LEU A 749
1.76A15.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP8
(SARS-CoV-2)		5 / 12
ILE B 132
LEU B 180
VAL B 167
THR B 187
LEU B 128
1.77A20.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP8
(SARS-CoV-2)		5 / 12
ILE D 107
ASP D 112
LEU D  95
THR D  89
LEU D  91
1.28A20.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
(SARS-CoV-2)		5 / 12
PRO A 809
ILE A 779
LEU A 614
VAL A 763
LEU A 786
1.39A15.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
(SARS-CoV-2)		5 / 12
ASP A 284
LEU A 280
LEU A 245
PHE A 317
LEU A 241
1.56A15.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
(SARS-CoV-2)		5 / 12
PRO A 677
ILE A 450
VAL A 667
SER A 397
MET A 542
1.65A15.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP8
(SARS-CoV-2)		5 / 12
ILE B 172
VAL B 130
VAL B 186
ILE B 185
LEU B 180
1.44A20.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
NSP8
(SARS-CoV-2)		5 / 12
ILE B 132
ASP A 390
LEU A 388
VAL A 405
LEU B 180
1.40A20.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
NSP8
(SARS-CoV-2)		5 / 12
PHE A 368
SER A 518
MET B  90
LEU B  91
THR B  89
1.78A15.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP7
NSP8
(SARS-CoV-2)		5 / 12
PRO D 121
VAL C  58
LEU D  95
LEU C  13
LEU D  91
1.36A20.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6m71 NSP12
NSP8
(SARS-CoV-2)		5 / 12
LEU A 514
PHE A 368
SER A 518
MET B  90
LEU B  91
1.75A15.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ILE A 724
ASP A 976
LEU A 734
LEU A 745
THR A 743
1.51A11.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)		6 / 12
PRO A1035
ILE A 852
VAL A 767
LEU A 847
MET A 770
LEU B 681
1.70A11.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6nb7 SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PHE C 782
VAL C1047
GLY C 867
PHE C1034
MET C 884
1.45A12.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6nb8 S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
HEAVY CHAIN
(Homo
sapiens)		5 / 12
PHE H  68
VAL H 123
GLY H  44
THR H 121
THR H  43
1.58A18.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6nb8 S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
HEAVY CHAIN
(Homo
sapiens)		6 / 12
PRO H 140
LEU H 203
VAL H 196
VAL H 198
SER H 202
THR H 174
1.77A18.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6nur NSP8
(SARSr-CoV)		5 / 12
ILE D 156
LEU D 128
VAL D 132
VAL D 130
LEU D 169
1.58A22.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6nur NSP12
NSP8
(SARSr-CoV)		5 / 12
PRO A 378
ILE B 119
VAL A 341
VAL A 330
LEU A 271
1.55A15.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIY_A_OAQA302_0
(SULFOTRANSFERASE)		6nur NSP12
NSP8
(SARSr-CoV)		5 / 11
PHE A 368
SER A 518
MET B  90
LEU B  91
THR B  89
1.74A14.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6nus NSP12
(SARSr-CoV)		5 / 12
ILE A 244
ASP A 465
LEU A 127
THR A 123
LEU A 212
1.47A14.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6nus NSP12
(SARSr-CoV)		5 / 12
PRO A 296
PHE A 287
LEU A 280
MET A 463
THR A 246
1.55A15.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
PHE A 800
VAL A1065
GLY A 885
PHE A1052
MET A 902
1.41A11.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
ILE B 805
VAL B1065
VAL B 722
LEU B 878
MET B1050
1.33A12.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 10
ILE B 805
LEU B 877
VAL B1033
THR B 881
THR B 723
1.59A11.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
ILE B 805
VAL B1065
VAL B 722
LEU B 878
MET B1050
1.36A11.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
ILE B 805
LEU B 877
VAL B1033
THR B 881
THR B 723
1.57A11.92
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
PRO A  39
LEU A 277
VAL A  42
ASP C 568
THR C 573
1.55A11.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6vw1 ACE2
(Homo
sapiens)		5 / 12
LEU A 444
ASP A 367
LEU A 370
THR A 276
THR A 294
1.30A17.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6vw1 ACE2
(Homo
sapiens)		5 / 12
ILE B 407
VAL B 573
VAL B 574
MET B 557
LEU B 558
1.16A17.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6vxs NSP3
(SARS-CoV-2)		5 / 12
LEU A  12
VAL A 142
VAL A 144
LEU A 122
THR A  13
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 10
ILE B 805
LEU B 877
VAL B1033
THR B 881
THR B 723
1.46A11.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
PHE C 800
VAL C1065
GLY C 885
PHE C1052
MET C 902
1.46A11.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
ILE B 805
LEU B 877
VAL B1033
THR B 881
THR B 723
1.49A11.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
ILE B 805
LEU B 877
VAL B1033
THR B 881
THR B 723
1.43A11.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
ILE C 805
LEU C 877
VAL C1033
THR C 881
THR C 723
1.42A11.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
PHE A 800
VAL A1065
GLY A 885
PHE A1052
MET A 902
1.46A11.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 10
ILE C 805
LEU C 877
VAL C1033
THR C 881
THR C 723
1.39A11.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
ILE C 805
LEU C 877
VAL C1033
THR C 881
THR C 723
1.38A11.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6w01 URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
PRO A  94
ILE A  80
LEU A  58
LEU A 120
THR A 106
1.55A20.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6w01 URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
ILE B 307
LEU B 300
VAL B 237
LEU B 332
THR B 341
1.57A19.26
None
None
None
None
CIT  B 408 (-3.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6w01 URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
LEU A 252
VAL A 276
ASP A 324
SER A 198
THR A 326
1.69A20.11
EDO  A 409 ( 4.6A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w37 PROTEIN 7A
(SARS-CoV-2)		5 / 12
VAL A  59
LEU A  41
PHE A  50
LEU A  62
THR A  46
1.76A11.98
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		5 / 12
PRO L 113
LEU L 201
VAL L 115
ILE L 117
LEU L 179
1.63A19.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		5 / 12
ILE L  75
LEU L  15
VAL L  83
LEU L  73
LEU L  47
1.53A19.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		5 / 12
ILE L 117
LEU L 175
VAL L 205
VAL L 196
SER L 177
1.58A19.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		5 / 12
LEU H 141
VAL H 211
ILE H 195
LEU H 159
THR H 193
1.73A19.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		5 / 12
PRO H 126
LEU H 189
VAL H 182
VAL H 184
THR H 160
1.78A18.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		5 / 12
ILE L  75
LEU L  15
VAL L  83
LEU L  73
LEU L  47
1.49A19.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		5 / 12
PRO L 113
LEU L 201
VAL L 115
ILE L 117
LEU L 179
1.64A19.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		5 / 12
LEU H 141
VAL H 182
VAL H 181
PHE L 118
THR H 135
1.78A19.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		6 / 12
PRO H 126
LEU H 189
VAL H 182
VAL H 184
SER H 188
THR H 160
1.77A19.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 SPIKE PROTEIN S1
(SARS-CoV-2)		5 / 12
VAL C 512
VAL C 511
ILE C 434
LEU C 387
PHE C 338
1.66A20.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		5 / 12
PRO H 126
LEU H 189
VAL H 184
SER H 188
THR H 160
1.71A19.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		5 / 12
LEU H 141
VAL H 182
VAL H 181
PHE L 118
THR H 135
1.78A19.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 SPIKE PROTEIN S1
(SARS-CoV-2)		5 / 12
PRO C 507
ILE C 418
VAL C 510
VAL C 401
LEU C 425
1.53A20.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		6 / 12
PRO H 126
LEU H 189
VAL H 182
VAL H 184
SER H 188
THR H 160
1.71A18.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		5 / 12
LEU H 141
VAL H 182
VAL H 181
PHE L 118
THR H 135
1.77A18.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6w4h NSP16
(SARS-CoV-2)		5 / 12
ILE A6926
VAL A6882
LEU A6924
THR A6880
LEU A6857
1.32A22.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6w4h NSP16
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.38A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6w4h NSP10
NSP16
(SARS-CoV-2)		5 / 10
LEU B4298
VAL A6882
PHE A7048
THR A6846
THR A6891
1.79A19.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6w61 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 10
LEU B4298
VAL A6882
PHE A7048
THR A6846
THR A6891
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU A7078
VAL A7057
LEU A7050
THR A6891
LEU A6887
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU A6825
LEU A7004
SER A6999
MET A6809
THR A6989
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
MET A6929
LEU A6898
ILE A6866
LEU A6883
LEU A6924
1.76A17.72
SAM  A7104 (-3.7A)
SAM  A7104 (-4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE A6925
VAL A6894
LEU A6924
LEU A6883
LEU A6887
1.70A17.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE A6926
VAL A6882
LEU A6924
THR A6880
LEU A6857
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w61 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 12
PRO A6878
ILE B4291
ILE B4352
THR B4364
LEU B4365
1.61A17.72
SAM  A7104 (-3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		6 / 12
PRO A6878
ILE A6926
VAL A6882
LEU A6924
LEU A6852
LEU A6857
1.55A
SAM  A7104 (-3.9A)
None
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
PRO A6878
ILE A6926
VAL A6882
LEU A6924
LEU A6852
1.64A
SAM  A7104 (-3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
ILE A 136
LEU A 115
VAL A 148
PHE A 140
THR A 175
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
PRO A  98
LEU A 109
LEU A 123
PHE A 116
LEU A  53
1.75A18.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
VAL A  36
VAL A  35
ILE A  23
PHE A   6
LEU A 126
1.66A18.75
None
None
AMP  A 201 ( 4.0A)
None
AMP  A 201 ( 4.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
ASP B 145
VAL B  16
PHE B 168
THR B  13
LEU B 160
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
PRO A 125
LEU A 127
VAL A  35
VAL A  36
THR A  33
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
PRO B 125
LEU B 127
VAL B  35
VAL B  36
THR B  33
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
VAL B  36
VAL B  35
ILE B  23
PHE B   6
LEU B 126
1.63A18.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
PRO A 125
LEU A 127
VAL A  35
VAL A  36
THR A  33
1.79A18.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
VAL A  35
ILE A  23
LEU A 153
PHE A   6
LEU A 126
1.62A18.75
None
AMP  A 201 ( 4.0A)
None
None
AMP  A 201 ( 4.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
PRO A  98
LEU A 109
LEU A 123
PHE A 116
LEU A  53
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
LEU A  43
VAL A  49
ILE A  23
LEU A 126
LEU A 153
1.53A
None
AMP  A 201 ( 3.7A)
AMP  A 201 ( 4.0A)
AMP  A 201 ( 4.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
LEU B  43
VAL B  49
ILE B  23
LEU B 126
LEU B 153
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
PRO B  98
LEU B 109
LEU B 123
PHE B 116
LEU B  53
1.79A18.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
VAL B  35
ILE B  23
LEU B 153
PHE B   6
LEU B 126
1.64A18.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
PRO B  98
LEU B 109
LEU B 123
PHE B 116
LEU B  53
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		6 / 12
PRO C6878
ILE C6926
VAL C6882
LEU C6924
LEU C6852
LEU C6857
1.56A17.19
SAM  C7105 ( 3.9A)
None
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
PRO C6878
VAL C6882
LEU C6924
SER C6903
LEU C6852
1.72A17.19
SAM  C7105 ( 3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP10
NSP16
(SARS-CoV-2)		5 / 12
PRO A6878
ILE B4291
ILE B4352
THR B4364
LEU B4365
1.54A17.19
SAM  A7102 ( 3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.55A17.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
PRO A6878
VAL A6882
LEU A6924
SER A6903
LEU A6852
1.71A17.19
SAM  A7102 ( 3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
PRO C6810
ILE C7005
LEU C6852
THR C6856
LEU C6857
1.78A17.19
FMT  C7109 ( 4.4A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6w75 NSP10
NSP16
(SARS-CoV-2)		5 / 10
LEU B4298
VAL A6882
PHE A7048
THR A6846
THR A6891
1.75A19.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
ILE A6926
VAL A6882
LEU A6924
THR A6880
LEU A6857
1.33A17.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.55A17.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP10
NSP16
(SARS-CoV-2)		5 / 12
LEU D4298
VAL C6882
PHE C7048
THR C6846
THR C6891
1.79A18.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
MET C6929
LEU C6898
ILE C6866
LEU C6883
LEU C6924
1.77A17.19
SAM  C7105 ( 3.5A)
SAM  C7105 ( 3.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP10
NSP16
(SARS-CoV-2)		5 / 12
PRO C6878
ILE D4291
ILE D4352
THR D4364
LEU D4365
1.57A17.19
SAM  C7105 ( 3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
PRO C6878
ILE C6926
VAL C6882
LEU C6924
LEU C6852
1.66A17.19
SAM  C7105 ( 3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6w75 NSP10
NSP16
(SARS-CoV-2)		5 / 10
LEU D4298
VAL C6882
PHE C7048
THR C6846
THR C6891
1.76A19.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.41A22.39
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP10
NSP16
(SARS-CoV-2)		5 / 12
LEU B4298
VAL A6882
PHE A7048
THR A6846
THR A6891
1.80A18.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		6 / 12
PRO A6878
ILE A6926
VAL A6882
LEU A6924
LEU A6852
LEU A6857
1.54A17.19
SAM  A7102 ( 3.8A)
None
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
VAL A7086
LEU A6924
LEU A6893
THR A6891
LEU A6887
1.70A17.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP10
NSP16
(SARS-CoV-2)		5 / 12
PRO A6878
ILE B4291
VAL B4295
THR B4364
LEU B4365
1.57A17.19
SAM  A7102 ( 3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
VAL C7094
VAL A7086
LEU A6893
THR A6891
LEU A6887
1.78A17.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
PRO A6878
ILE A6926
VAL A6882
LEU A6924
LEU A6852
1.64A17.19
SAM  A7102 ( 3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
MET A6929
LEU A6898
ILE A6866
LEU A6883
LEU A6924
1.74A17.19
SAM  A7102 ( 3.5A)
SAM  A7102 ( 3.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
ILE C6925
LEU C6909
VAL C7086
LEU C6959
PHE C6954
1.60A17.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
MET A7045
VAL A6842
LEU A6852
SER A7041
LEU A6883
1.78A17.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
ILE C6925
LEU C6909
VAL C7086
LEU C6959
PHE C6954
1.45A22.39
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
ILE C6926
VAL C6882
LEU C6924
THR C6880
LEU C6857
1.33A17.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
ILE A 123
LEU A 125
THR A 259
MET A 206
LEU A 178
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
ILE A 276
ASP A 286
LEU A 289
LEU A 253
THR A 291
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
PHE B 304
LEU B 101
GLY B 163
MET B 169
THR B 168
1.61A20.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
PHE A 304
LEU A 101
GLY A 163
MET A 169
THR A 168
1.61A20.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
PHE C 304
LEU C 101
GLY C 163
MET C 169
THR C 168
1.59A20.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6w9q 3C-LIKE PROTEINASE
PEPTIDE, NSP9 FUSION
(SARS-CoV-2)		5 / 12
LEU A  69
VAL A  41
GLY A  37
THR A  67
THR A  35
1.56A21.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wcf NSP3
(SARS-CoV-2)		5 / 12
LEU A  43
VAL A  49
ILE A  23
LEU A 126
LEU A 153
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wcf NSP3
(SARS-CoV-2)		5 / 12
PRO A  98
LEU A 109
LEU A 123
PHE A 116
LEU A  53
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wen NSP3
(SARS-CoV-2)		5 / 12
LEU A  43
VAL A  49
ILE A  23
LEU A 126
LEU A 153
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wen NSP3
(SARS-CoV-2)		5 / 12
VAL A  35
ILE A  23
LEU A 153
PHE A   6
LEU A 126
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wen NSP3
(SARS-CoV-2)		5 / 12
PRO A  98
LEU A 109
LEU A 123
PHE A 116
LEU A  53
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6wen NSP3
(SARS-CoV-2)		5 / 12
PRO A 125
LEU A 127
VAL A  35
VAL A  36
THR A  33
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6wen NSP3
(SARS-CoV-2)		5 / 12
PRO A 125
LEU A 127
VAL A  35
VAL A  36
THR A  33
1.79A21.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wen NSP3
(SARS-CoV-2)		5 / 12
PRO A 125
LEU A 127
VAL A  35
VAL A  36
THR A  33
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6wey NSP3
(SARS-CoV-2)		5 / 12
PRO A 329
LEU A 331
VAL A 239
VAL A 240
THR A 237
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wey NSP3
(SARS-CoV-2)		5 / 12
PRO A 302
LEU A 313
LEU A 327
PHE A 320
LEU A 257
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wiq NSP8
(SARS-CoV-2)		5 / 12
ILE B 132
LEU B 180
VAL B 167
THR B 187
LEU B 128
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wiq NSP7
NSP8
(SARS-CoV-2)		5 / 12
PRO B 121
VAL A  58
LEU B  95
LEU A  13
LEU B  91
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wiq NSP7
NSP8
(SARS-CoV-2)		5 / 12
ILE B 107
LEU A  56
LEU B  91
THR A   9
LEU A  13
1.01A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wiq NSP7
NSP8
(SARS-CoV-2)		5 / 12
ILE B 106
ILE B 119
LEU A  60
LEU A  13
LEU A  59
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
PRO C 309
ILE D 337
LEU D 339
SER D 310
LEU D 353
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
PRO E 309
ILE F 337
LEU F 339
SER F 310
LEU F 353
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
PRO D 309
ILE C 337
LEU C 339
SER C 310
LEU C 353
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		6 / 12
PRO A6878
ILE A6926
VAL A6882
LEU A6924
LEU A6852
LEU A6857
1.54A
SAH  A7102 (-3.8A)
None
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE C7088
ASP C6906
LEU C6892
VAL C6865
ILE C6925
1.75A21.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE C6926
VAL C6882
LEU C6924
THR C6880
LEU C6857
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE A6926
VAL A6882
LEU A6924
THR A6880
LEU A6857
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 10
LEU B4298
VAL A6882
PHE A7048
THR A6846
THR A6891
1.74A
FMT  B4403 (-4.7A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
PRO C6878
VAL C6882
LEU C6924
SER C6903
LEU C6852
1.71A
SAH  C7102 (-3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 12
PRO A6878
ILE B4291
ILE B4352
THR B4364
LEU B4365
1.56A
SAH  A7102 (-3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
PRO A6878
VAL A6882
LEU A6924
SER A6903
LEU A6852
1.71A
SAH  A7102 (-3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
PRO C6878
ILE C6926
VAL C6882
LEU C6924
LEU C6852
1.66A
SAH  C7102 (-3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 10
LEU D4298
VAL C6882
PHE C7048
THR C6846
THR C6891
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		6 / 12
PRO C6878
ILE C6926
VAL C6882
LEU C6924
LEU C6852
LEU C6857
1.57A
SAH  C7102 (-3.8A)
None
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU C6909
VAL A7094
LEU C6924
LEU C6887
THR C6891
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 12
LEU B4298
VAL A6882
PHE A7048
THR A6846
THR A6891
1.79A18.08
FMT  B4403 (-4.7A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE C6925
LEU C6909
VAL C7086
LEU C6959
PHE C6954
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
PRO A6878
ILE A6926
VAL A6882
LEU A6924
LEU A6852
1.64A
SAH  A7102 (-3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU C6825
LEU C7004
SER C6999
MET C6809
THR C6989
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
LEU B 113
LEU B  56
PHE B 110
THR B 165
LEU B 167
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
LEU C 113
LEU C  56
PHE C 110
THR C 165
LEU C 167
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
LEU D 113
LEU D  56
PHE D 110
THR D 165
LEU D 167
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 12
LEU A 113
LEU A  56
PHE A 110
THR A 165
LEU A 167
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
ILE A6926
VAL A6882
LEU A6924
THR A6880
LEU A6857
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP10
NSP16
(SARS-CoV-2)		5 / 12
LEU D4298
VAL C6882
PHE C7048
THR C6846
THR C6891
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
ILE C6926
VAL C6882
LEU C6924
THR C6880
LEU C6857
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
ILE C7088
ASP C6906
LEU C6892
VAL C6865
ILE C6925
1.73A21.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
PRO C6878
ILE C6926
VAL C6882
LEU C6924
LEU C6852
1.66A
SFG  C7103 ( 3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6wkq NSP10
NSP16
(SARS-CoV-2)		5 / 10
LEU D4298
VAL C6882
PHE C7048
THR C6846
THR C6891
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
ILE C6925
LEU C6909
VAL C7086
LEU C6959
PHE C6954
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP10
NSP16
(SARS-CoV-2)		5 / 12
PRO A6878
ILE B4291
ILE B4352
THR B4364
LEU B4365
1.54A
SFG  A7103 ( 3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
PRO A6878
VAL A6882
LEU A6924
SER A6903
LEU A6852
1.70A
SFG  A7103 ( 3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
PRO C6878
VAL C6882
LEU C6924
SER C6903
LEU C6852
1.71A
SFG  C7103 ( 3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		6 / 12
PRO C6878
ILE C6926
VAL C6882
LEU C6924
LEU C6852
LEU C6857
1.57A
SFG  C7103 ( 3.9A)
None
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
ILE C6925
LEU C6909
VAL C7086
LEU C6959
PHE C6954
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		6 / 12
PRO A6878
ILE A6926
VAL A6882
LEU A6924
LEU A6852
LEU A6857
1.54A
SFG  A7103 ( 3.8A)
None
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
PRO A6878
ILE A6926
VAL A6882
LEU A6924
LEU A6852
1.64A
SFG  A7103 ( 3.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6wkq NSP10
NSP16
(SARS-CoV-2)		5 / 10
LEU B4298
VAL A6882
PHE A7048
THR A6846
THR A6891
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
LEU B 168
VAL B 173
GLY B 126
PHE B 177
THR B 175
1.72A22.25
None
None
ACT  B 408 (-4.2A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
LEU B 252
VAL B 276
ASP B 324
SER B 198
THR B 326
1.72A22.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
LEU A 252
VAL A 276
ASP A 324
SER A 198
THR A 326
1.70A22.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
PRO B  94
ILE B  80
LEU B  58
LEU B 120
THR B 106
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
LEU A 168
VAL A 173
GLY A 126
PHE A 177
THR A 175
1.67A22.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
PRO A  94
ILE A  80
LEU A  58
LEU A 120
THR A 106
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
PRO A 191
ILE A  72
LEU A  73
THR A 326
THR A 121
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
LEU A  67
VAL A  91
VAL A  77
LEU A  30
LEU A  32
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
PRO B  98
LEU B 109
LEU B 123
PHE B 116
LEU B  53
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
LEU D  12
VAL D 142
VAL D 144
LEU D 122
THR D  13
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
VAL D  35
ILE D  23
LEU D 153
PHE D   6
LEU D 126
1.55A
None
APR  D 201 (-3.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
PRO C  98
LEU C 109
LEU C 123
PHE C 116
LEU C  53
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
PRO A  98
LEU A 109
LEU A 123
PHE A 116
LEU A  53
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
PRO D  98
LEU D 109
LEU D 123
PHE D 116
LEU D  53
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		6 / 12
PRO A6878
ILE A6926
VAL A6882
LEU A6924
LEU A6852
LEU A6857
1.54A
SAH  A7101 (-3.9A)
None
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE A6925
LEU A6909
VAL A7086
LEU A6959
PHE A6954
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wq3 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 12
MET A7045
LEU B4298
VAL A6882
THR A6846
LEU A7052
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
PRO A6878
ILE A6926
VAL A6882
LEU A6924
LEU A6852
1.64A
SAH  A7101 (-3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
ILE A6926
VAL A6882
LEU A6924
THR A6880
LEU A6857
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU A7078
VAL A7057
LEU A7050
THR A6891
LEU A6887
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6wq3 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 10
LEU B4298
VAL A6882
PHE A7048
THR A6846
THR A6891
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wq3 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 12
PRO A6878
ILE B4291
ILE B4352
THR B4364
LEU B4365
1.55A
SAH  A7101 (-3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
LEU A6825
LEU A7004
SER A6999
MET A6809
THR A6989
1.73A
GTA  A7102 (-3.8A)
None
GTA  A7102 (-2.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wq3 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		5 / 12
PRO A6878
ILE B4291
VAL B4295
THR B4364
LEU B4365
1.56A
SAH  A7101 (-3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 12
PRO D 121
VAL C  58
LEU D  95
LEU C  13
LEU D  91
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wqd NSP8
(SARS-CoV-2)		5 / 12
ILE D 132
LEU D 180
VAL D 167
THR D 187
LEU D 128
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 12
ILE D 107
LEU C  56
LEU D  91
THR C   9
LEU C  13
1.00A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 12
MET D  94
LEU D  91
VAL A  12
VAL A  11
MET B  90
1.66A20.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wqd NSP8
(SARS-CoV-2)		5 / 12
ILE B 132
LEU B 180
VAL B 167
THR B 187
LEU B 128
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 12
ILE B 107
LEU A  56
LEU B  91
THR A   9
LEU A  13
0.99A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 12
MET B  94
LEU B  91
VAL C  12
VAL C  11
MET D  90
1.70A20.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 12
PRO B 121
VAL A  58
LEU B  95
LEU A  13
LEU B  91
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 12
ILE D 106
ILE D 119
LEU C  60
LEU C  13
LEU C  59
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 12
ILE B 106
ILE B 119
LEU A  60
LEU A  13
LEU A  59
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
ILE A 249
LEU A 250
PHE A 294
LEU A 242
LEU A 205
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
HIS A  41
ILE A  43
VAL A  20
LEU A  58
THR A  24
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
LEU A  67
VAL A  91
VAL A  77
LEU A  30
LEU A  32
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6wrh PEPTIDASE C16
(SARS-CoV-2)		5 / 12
PHE A 304
LEU A 101
GLY A 163
MET A 169
THR A 168
1.64A19.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6wrh PEPTIDASE C16
(SARS-CoV-2)		5 / 12
ILE A 276
ASP A 286
LEU A 289
LEU A 253
THR A 291
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
LEU A  67
VAL A  91
VAL A  77
LEU A  30
LEU A  32
1.44A19.01
DMS  A 402 ( 4.8A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ILE A 249
LEU A 250
PHE A 294
LEU A 242
LEU A 205
1.36A19.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.44A19.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.68A19.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
ILE D 106
ILE D 119
LEU C  60
LEU C  13
LEU C  59
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
ILE B 107
LEU A  56
LEU B  91
THR A   9
LEU A  13
1.00A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
PRO B 121
VAL A  58
LEU B  95
LEU A  13
LEU B  91
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
PRO D 121
ILE D 156
VAL D 130
ILE D 185
LEU D 169
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
ILE B 106
ILE B 119
LEU A  60
LEU A  13
LEU A  59
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
PRO B 121
ILE B 156
VAL B 130
ILE B 185
LEU B 169
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
MET B  94
LEU B  91
VAL C  12
VAL C  11
MET D  90
1.66A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
ILE B 132
LEU B 180
VAL B 167
THR B 187
LEU B 128
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
ILE D 132
LEU D 180
VAL D 167
THR D 187
LEU D 128
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
MET D  94
LEU D  91
VAL A  12
VAL A  11
MET B  90
1.67A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
PRO D 121
VAL C  58
LEU D  95
LEU C  13
LEU D  91
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
ILE D 107
LEU C  56
LEU D  91
THR C   9
LEU C  13
0.97A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 12
LEU B  91
VAL C  12
VAL C  11
LEU D  95
LEU D 103
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yi3 NUCLEOPROTEIN
(SARS-CoV-2)		5 / 10
ASP A  41
LEU A  99
ASP A 104
THR A 101
THR A 108
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yi3 NUCLEOPROTEIN
(SARS-CoV-2)		5 / 10
ILE A 106
ASP A  41
LEU A  99
ASP A 104
THR A 101
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		6yi3 NUCLEOPROTEIN
(SARS-CoV-2)		5 / 12
PRO A 122
PHE A  13
LEU A 121
VAL A  32
GLY A  74
1.79A16.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6yi3 NUCLEOPROTEIN
(SARS-CoV-2)		5 / 12
ILE A 106
ASP A  41
LEU A  99
ASP A 104
THR A 101
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
ILE L 123
LEU L 181
VAL L 211
VAL L 202
SER L 183
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
PRO L 119
LEU L 142
LEU H 142
PHE L 124
LEU H 193
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
ILE L  81
LEU L  15
VAL L  89
LEU L  79
LEU L  53
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
LEU H 163
VAL H 185
VAL H 186
SER H 165
THR L 170
1.75A21.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
ILE C  81
LEU C  15
VAL C  89
LEU C  79
LEU C  53
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
ILE C 123
LEU C 181
VAL C 211
VAL C 202
SER C 183
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 12
LEU B 193
VAL B 186
VAL B 188
SER B 192
THR B 164
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 12
LEU B 193
VAL B 186
VAL B 188
SER B 192
THR B 164
1.64A21.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yla HEAVY CHAIN
(Homo
sapiens)		6 / 12
PRO H 130
LEU H 193
VAL H 186
VAL H 188
SER H 192
THR H 164
1.67A21.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 12
LEU H 193
VAL H 186
VAL H 188
SER H 192
THR H 164
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 12
PRO H 130
LEU H 193
VAL H 186
SER H 192
THR H 164
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
PRO C 119
LEU C 207
VAL C 121
ILE C 123
LEU C 185
1.65A19.85
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
LEU H 163
VAL H 185
VAL H 186
SER H 165
THR L 170
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
PRO L 119
LEU L 207
VAL L 121
ILE L 123
LEU L 185
1.64A19.85
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
LEU B 163
VAL B 185
VAL B 186
SER B 165
THR C 170
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
ILE C  81
LEU C  15
VAL C  89
LEU C  79
LEU C  53
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
PRO C 119
LEU C 142
LEU B 142
PHE C 124
LEU B 193
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 12
PRO H 130
LEU H 193
VAL H 186
VAL H 188
THR H 164
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
LEU B 163
VAL B 185
VAL B 186
SER B 165
THR C 170
1.77A21.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6ym0 LIGHT CHAIN
(Homo
sapiens)		5 / 12
PRO L 119
LEU L 207
VAL L 121
ILE L 123
LEU L 185
1.71A19.85
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6ym0 HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
PRO L 119
LEU L 142
LEU H 142
PHE L 124
LEU H 193
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ym0 LIGHT CHAIN
(Homo
sapiens)		5 / 12
ILE L  81
LEU L  15
VAL L  89
LEU L  79
LEU L  53
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ym0 LIGHT CHAIN
(Homo
sapiens)		5 / 12
ILE L 123
LEU L 181
VAL L 211
VAL L 202
SER L 183
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6ym0 HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
LEU L 142
VAL L 121
LEU H 142
PHE L 124
LEU H 193
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6ym0 HEAVY CHAIN
(Homo
sapiens)		6 / 12
PRO H 130
LEU H 193
VAL H 186
VAL H 188
SER H 192
THR H 164
1.72A21.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
HIS A  41
ILE A  43
VAL A  20
LEU A  58
THR A  24
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
LEU A  67
VAL A  91
VAL A  77
LEU A  30
LEU A  32
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)		5 / 12
PRO L 119
LEU L 142
LEU H 142
PHE L 124
LEU H 193
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
ILE L  81
LEU L  15
VAL L  89
LEU L  79
LEU L  53
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)		5 / 12
PRO C 119
LEU C 142
LEU B 142
PHE C 124
LEU B 193
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
ILE L 123
LEU L 181
VAL L 211
VAL L 202
SER L 183
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 12
PRO H 130
LEU H 193
VAL H 186
SER H 192
THR H 164
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)		5 / 12
LEU H 163
VAL H 185
VAL H 186
SER H 165
THR L 170
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yor IGG H CHAIN
(Homo
sapiens)		6 / 12
PRO B 130
LEU B 193
VAL B 186
VAL B 188
SER B 192
THR B 164
1.67A21.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
PRO L 119
LEU L 207
VAL L 121
ILE L 123
LEU L 185
1.64A19.85
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 12
PRO H 130
LEU H 193
VAL H 186
VAL H 188
THR H 164
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)		5 / 12
LEU B 163
VAL B 185
VAL B 186
SER B 165
THR C 170
1.74A21.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
PRO C 119
LEU C 207
VAL C 121
ILE C 123
LEU C 185
1.63A19.85
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 12
LEU B 193
VAL B 186
VAL B 188
SER B 192
THR B 164
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
ILE C 123
LEU C 181
VAL C 211
VAL C 202
SER C 183
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yor IGG H CHAIN
(Homo
sapiens)		6 / 12
PRO H 130
LEU H 193
VAL H 186
VAL H 188
SER H 192
THR H 164
1.67A21.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 12
PRO B 130
LEU B 193
VAL B 186
VAL B 188
THR B 164
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 12
PRO B 130
LEU B 193
VAL B 186
SER B 192
THR B 164
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)		5 / 12
LEU B 163
VAL B 185
VAL B 186
SER B 165
THR C 170
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 12
LEU H 193
VAL H 186
VAL H 188
SER H 192
THR H 164
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
ILE C  81
LEU C  15
VAL C  89
LEU C  79
LEU C  53
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)		5 / 12
LEU H 163
VAL H 185
VAL H 186
SER H 165
THR L 170
1.75A21.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ILE A 249
LEU A 250
PHE A 294
LEU A 242
LEU A 205
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.67A
None
None
PEG  A 404 (-2.9A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
LEU A  67
VAL A  91
VAL A  77
LEU A  30
LEU A  32
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.47A
None
PEG  A 405 (-4.1A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU C  43
VAL C  49
ILE C  23
LEU C 126
LEU C 153
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU D  43
VAL D  49
ILE D  23
LEU D 126
LEU D 153
1.53A
None
EDO  D 209 (-4.6A)
EDO  D 208 (-4.0A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU B  43
VAL B  49
ILE B  23
LEU B 126
LEU B 153
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU E  43
VAL E  49
ILE E  23
LEU E 126
LEU E 153
1.54A
None
None
EDO  E 205 (-4.2A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO C  98
LEU C 109
LEU C 123
PHE C 116
LEU C  53
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO B  98
LEU B 109
LEU B 123
PHE B 116
LEU B  53
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU A  43
VAL A  49
ILE A  23
LEU A 126
LEU A 153
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASP E 145
VAL E  16
PHE E 168
THR E  13
LEU E 160
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO D 125
LEU D 127
VAL D  35
VAL D  36
THR D  33
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO D  98
LEU D 109
LEU D 123
PHE D 116
LEU D  53
1.75A
None
EDO  D 204 ( 4.5A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO D 125
LEU D 127
VAL D  35
VAL D  36
THR D  33
1.79A23.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO D 125
LEU D 127
VAL D  35
VAL D  36
THR D  33
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO B  98
LEU B 109
LEU B 123
PHE B 116
LEU B  53
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO C  98
LEU C 109
LEU C 123
PHE C 116
LEU C  53
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO A  98
LEU A 109
LEU A 123
PHE A 116
LEU A  53
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASP C 145
VAL C  16
PHE C 168
THR C  13
LEU C 160
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASP B 145
LEU B 164
PHE B 168
THR B  13
LEU B 160
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
LEU A  43
VAL A  49
ILE A  23
LEU A 126
LEU A 153
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO C  98
LEU C 109
LEU C 123
PHE C 116
LEU C  53
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ASP B 145
VAL B  16
PHE B 168
THR B  13
LEU B 160
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO C 125
LEU C 127
VAL C  35
VAL C  36
THR C  33
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
PRO B  98
LEU B 109
LEU B 123
PHE B 116
LEU B  53
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7bqy MAIN PROTEASE
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bqy MAIN PROTEASE
(SARS-CoV-2)		5 / 12
ILE A 249
LEU A 250
PHE A 294
LEU A 242
LEU A 205
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bqy MAIN PROTEASE
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7bqy MAIN PROTEASE

(SARS-CoV-2;
synthetic
construct)		5 / 12
LEU A  30
VAL A  20
LEU C   4
SER A 147
THR A  25
1.72A
None
None
PJE  C   5 ( 4.1A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bqy MAIN PROTEASE
(SARS-CoV-2)		5 / 12
LEU A  67
VAL A  91
VAL A  77
LEU A  30
LEU A  32
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
MET A 755
ILE A 696
LEU A 749
VAL A 475
LEU A 638
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP7
NSP8
(SARS-CoV-2)		5 / 12
ILE D 107
LEU C  56
LEU D  91
THR C   9
LEU C  13
1.00A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 12
PRO A 378
ILE B 119
VAL A 341
VAL A 330
LEU A 271
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
ASP A 284
LEU A 280
LEU A 245
PHE A 317
LEU A 241
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
LEU A 119
VAL A  72
VAL A  71
LEU A   8
THR A  24
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
LEU A  49
VAL A  31
PHE A  35
LEU A 119
THR A 120
1.77A15.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 12
PHE A 368
SER A 518
MET B  90
LEU B  91
THR B  89
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 12
VAL B 131
LEU A 673
THR A 393
THR A 402
LEU A 401
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP8
(SARS-CoV-2)		5 / 12
ILE D 132
LEU D 180
VAL D 167
THR D 187
LEU D 128
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 12
ILE B 132
ASP A 390
LEU A 388
VAL A 405
LEU B 180
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP7
NSP8
(SARS-CoV-2)		5 / 12
ILE D 106
ILE D 119
LEU C  60
LEU C  13
LEU C  59
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
PRO A 809
LEU A 602
VAL A 763
ILE A 757
LEU A 749
1.74A15.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
ILE A 632
VAL A 693
LEU A 663
MET A 626
THR A 680
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
PRO A 296
LEU A 280
LEU A 186
MET A 463
THR A 246
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
PRO A 809
ILE A 779
LEU A 614
VAL A 763
LEU A 786
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
PRO A 809
LEU A 614
VAL A 763
ILE A 757
PHE A 753
1.69A15.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
ASP A 164
LEU A 146
PHE A 134
THR A 248
LEU A 178
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 12
PRO A 378
ILE B 119
VAL A 341
VAL A 330
LEU A 271
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
PRO A 296
PHE A 287
LEU A 280
MET A 463
THR A 246
1.70A14.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
ILE A 715
LEU A 708
VAL A 776
SER A 709
THR A 769
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
ASP A  29
LEU A  49
PHE A  35
LEU A 119
THR A 120
1.71A15.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP7
NSP8
(SARS-CoV-2)		5 / 12
PRO D 121
VAL C  58
LEU D  95
LEU C  13
LEU D  91
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP8
(SARS-CoV-2)		5 / 12
ILE B 132
LEU B 180
VAL B 167
THR B 187
LEU B 128
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIY_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 11
PHE A 368
SER A 518
MET B  90
LEU B  91
THR B  89
1.63A15.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 12
PRO A 328
LEU B 117
VAL A 675
LEU A 389
THR A 393
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7btf NSP12
(SARS-CoV-2)		5 / 12
ILE A 632
VAL A 693
LEU A 663
MET A 626
THR A 680
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 12
LEU A 388
VAL B 130
ILE B 156
LEU B 153
THR B 146
1.63A15.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		5 / 12
ILE A 281
VAL A 212
LEU A 287
MET A 264
LEU A 268
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		6 / 12
ILE A 249
ILE A 200
LEU A 250
LEU A 242
THR A 201
LEU A 205
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
PRO A 378
ILE B 119
VAL A 341
VAL A 330
LEU A 271
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B4Y_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		7bv1 NSP12
(SARS-CoV-2)		5 / 10
ILE A 837
LEU A 885
VAL A 860
ASP A 865
THR A 912
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 12
ASP A 164
LEU A 146
PHE A 134
THR A 248
LEU A 178
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
LEU A 388
VAL B 130
ILE B 156
LEU B 153
THR B 146
1.67A14.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP7
(SARS-CoV-2)		5 / 12
ILE C  39
LEU A 437
VAL C  12
VAL C  11
LEU C  35
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
PRO A 328
ILE B 107
LEU A 329
ILE A 333
LEU B  98
1.74A14.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
PRO A 537
ILE B 120
ILE A 333
LEU B 103
LEU B  98
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
VAL B  83
LEU A 366
SER A 518
MET B  90
LEU B  91
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 12
ASP A 284
LEU A 280
LEU A 245
PHE A 317
LEU A 241
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP7
NSP8
(SARS-CoV-2)		5 / 12
ILE D 107
LEU C  56
LEU D  91
THR C   9
LEU C  13
1.06A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIY_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 11
VAL B  83
PHE A 368
SER A 518
LEU B  91
THR B  89
1.80A21.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
LEU A 514
VAL B  83
PHE A 368
SER A 518
LEU B  91
1.59A14.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 12
ILE A 244
ASP A 465
LEU A 127
THR A 123
LEU A 212
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
ILE B 132
ASP A 390
LEU A 388
VAL A 405
LEU B 180
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 12
ILE A 171
LEU A 142
PHE A 157
LEU A 178
LEU A 131
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 12
PRO A 296
PHE A 287
LEU A 280
MET A 463
THR A 246
1.73A14.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
PRO A 537
ILE B 120
VAL A 342
LEU B 103
LEU B  98
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP7
NSP8
(SARS-CoV-2)		5 / 12
ILE D 106
ILE D 119
LEU C  60
LEU C  13
LEU C  59
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
PRO A 378
ASP A 377
PHE A 506
SER A 561
MET B  94
1.70A14.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 12
LEU A 727
VAL A 476
VAL A 475
LEU A 308
LEU A 636
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP7
(SARS-CoV-2)		5 / 12
ILE C  39
LEU A 437
VAL C  12
VAL C  11
LEU C  35
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
PRO A 378
ILE B 119
VAL A 341
VAL A 330
LEU A 271
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 12
LEU A 280
ILE A 466
LEU A 245
PHE A 317
LEU A 241
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
VAL B  83
LEU A 366
PHE A 368
SER A 518
LEU B  91
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 12
PRO A 328
LEU B 117
VAL A 675
LEU A 389
THR A 393
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7bv1 NSP12
NSP7
(SARS-CoV-2)		5 / 12
ILE C  39
LEU A 437
VAL C  12
VAL C  11
LEU C  35
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
LEU A 280
ILE A 466
LEU A 245
PHE A 317
LEU A 241
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
ILE A 244
ASP A 465
LEU A 127
THR A 123
LEU A 212
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
ILE A 715
LEU A 708
VAL A 776
SER A 709
THR A 769
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
ILE A 632
VAL A 693
LEU A 663
MET A 626
THR A 680
1.68A
None
None
None
None
F86  P 102 ( 4.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
PRO A 809
LEU A 614
VAL A 763
ILE A 757
PHE A 753
1.73A14.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
NSP8
(SARS-CoV-2)		5 / 12
ILE B 132
ASP A 390
LEU A 388
VAL A 405
LEU B 180
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
ASP A 164
LEU A 146
PHE A 134
THR A 248
LEU A 178
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
ASP A 284
LEU A 280
LEU A 245
PHE A 317
LEU A 241
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
HIS A 309
PHE A 313
LEU A 308
MET A 242
THR A 246
1.76A14.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_B_OAQB302_0
(SULFOTRANSFERASE)		7bv2 NSP12
NSP8
(SARS-CoV-2)		5 / 12
LEU A 388
VAL B 130
ILE B 156
LEU B 153
THR B 146
1.67A14.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
NSP8
(SARS-CoV-2)		5 / 12
ILE B 106
ASP B  99
LEU B  98
VAL A 341
LEU A 271
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIW_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
LEU A 727
VAL A 476
VAL A 475
LEU A 308
LEU A 636
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
NSP8
(SARS-CoV-2)		6 / 12
LEU A 366
PHE A 368
SER A 518
MET B  90
LEU B  91
THR B  89
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
PRO A 296
PHE A 287
LEU A 280
MET A 463
THR A 246
1.78A14.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B50_A_OAQA302_0
(SULFOTRANSFERASE
OXAMNIQUINE
RESISTANCE PROTEIN)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
HIS A 642
LEU A 636
ASP A 684
SER A 635
THR A 565
1.75A14.60
 ZN  A1002 (-3.2A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP12
NSP7
(SARS-CoV-2)		5 / 12
ILE C  39
LEU A 437
VAL C  12
VAL C  11
LEU C  56
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B54_A_OAQA302_0
(SULFOTRANSFERASE)		7bv2 NSP8
(SARS-CoV-2)		5 / 12
ILE B 132
LEU B 180
VAL B 167
THR B 187
LEU B 128
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B52_A_OAQA302_0
(SULFOTRANSFERASE)		7jtl NONSTRUCTURAL
PROTEIN NS8
(SARS-CoV-2)		5 / 12
PRO A  38
VAL A 114
PHE A 108
SER A 103
LEU A  98
1.34A15.56
None